OncoSil Medical LtdASX: OSL

Appendix 4G and Corporate Governance Statement

· Issued by OncoSil Medical Ltd via ASX

Filed with ASX ·

Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity OncoSil Medical Limited ABN/ARBN Financial year ended: 89 113 824 141 30 June 2026 Our...

View Attachment

6ix hasn’t read this filing yet.

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases